At the heart of the MenoPause Consortium is a collaborative network of clinicians, researchers, occupational physicians, and other stakeholders. Together, they strive to identify the adverse effects of the menopause transition and develop personalized strategies to prevent them. Key questions guide their mission: Why do some women experience symptoms while others do not? How can lifestyle advice or hormone therapy prevent these symptoms? What are the long-term health risks for each individual, and how can they be mitigated? By addressing these questions, the consortium aims to empower women to continue participating fully in society throughout their menopause journey.

The MenoPause Consortium collaborates closely with Erasmus MC, a leading medical center in the Netherlands, to advance research and clinical practices related to menopause. This partnership leverages Erasmus MC’s extensive expertise in women’s health and genomics, particularly through its Department of Genomics. By integrating clinical insights with cutting-edge genomic research, the consortium aims to develop personalized strategies that address the diverse challenges women face during the menopause transition. This collaborative approach ensures that scientific discoveries are effectively translated into practical solutions, enhancing the health and well-being of women during and after menopause.